Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Marc Phelip

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Bulletin Du Cancer|July 23, 2022
Prognostic factors of pelvic MRI at the initial workflow in locally advanced rectal cancer: Focus on extra mural venous invasion and tumour depositsAlexandre Mayaud, Amal Bousarsar, Saïd Soltani, et al.
World Journal of Surgery|November 19, 2020
What is the Best Therapeutic Strategy for Metachronous Resectable Colorectal Liver Metastases After Adjuvant Oxaliplatin-Based Chemotherapy? A Multidisciplinary Inter-Group SurveyAlexandra Nassar, Jean Marc Phelip, Diane Goéré, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseasesXavier Roblin, Hubert Marotte, Melanie Rinaudo, et al.
Inflammatory Bowel Diseases|September 10, 2013
Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective studyStephane Paul, Emilie Del Tedesco, Hubert Marotte, et al.
Annals of Surgical Oncology|January 3, 2024
Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early RecurrenceRémi Grange, Pascal Rousset, Nicolas Williet, et al.
Gastroenterologie Clinique Et Biologique|May 18, 2004
Regional variations in management of rectal cancer in FranceJean-Marc Phelip, Guy Launoy, Marc Colonna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2018
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III studyJean-Marc Phelip, Julien Edeline, Jean-Frédéric Blanc, et al.
Future Oncology (London, England)|May 20, 2021
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohortJean-Philippe Metges, Dominique Genet, David Tougeron, et al.
The American Journal of Gastroenterology|July 27, 2011
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitisXavier Roblin, Sylvie Pillet, Abderrahim Oussalah, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 23, 2024
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging conceptCaroline Prouvot, Myriam Boumaiza, Khawla Maoui, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Bulletin Du Cancer|July 23, 2022
Prognostic factors of pelvic MRI at the initial workflow in locally advanced rectal cancer: Focus on extra mural venous invasion and tumour depositsAlexandre Mayaud, Amal Bousarsar, Saïd Soltani, et al.
World Journal of Surgery|November 19, 2020
What is the Best Therapeutic Strategy for Metachronous Resectable Colorectal Liver Metastases After Adjuvant Oxaliplatin-Based Chemotherapy? A Multidisciplinary Inter-Group SurveyAlexandra Nassar, Jean Marc Phelip, Diane Goéré, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2013
Association between pharmacokinetics of adalimumab and mucosal healing in patients with inflammatory bowel diseasesXavier Roblin, Hubert Marotte, Melanie Rinaudo, et al.
Inflammatory Bowel Diseases|September 10, 2013
Therapeutic drug monitoring of infliximab and mucosal healing in inflammatory bowel disease: a prospective studyStephane Paul, Emilie Del Tedesco, Hubert Marotte, et al.
Annals of Surgical Oncology|January 3, 2024
Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early RecurrenceRémi Grange, Pascal Rousset, Nicolas Williet, et al.
Gastroenterologie Clinique Et Biologique|May 18, 2004
Regional variations in management of rectal cancer in FranceJean-Marc Phelip, Guy Launoy, Marc Colonna, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 25, 2018
Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III studyJean-Marc Phelip, Julien Edeline, Jean-Frédéric Blanc, et al.
Future Oncology (London, England)|May 20, 2021
Real-world safety and effectiveness of regorafenib in metastatic colorectal cancer: the French CORRELATE cohortJean-Philippe Metges, Dominique Genet, David Tougeron, et al.
The American Journal of Gastroenterology|July 27, 2011
Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitisXavier Roblin, Sylvie Pillet, Abderrahim Oussalah, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 23, 2024
Pancreatic steatosis is a strong risk factor for post-ERCP pancreatitis: An emerging conceptCaroline Prouvot, Myriam Boumaiza, Khawla Maoui, et al.
Pageof 12